164 related articles for article (PubMed ID: 16452211)
1. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
Shen Y; Jia Z; Nagele RG; Ichikawa H; Goldberg GS
Cancer Res; 2006 Feb; 66(3):1543-52. PubMed ID: 16452211
[TBL] [Abstract][Full Text] [Related]
2. Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration.
Li X; Shen Y; Ichikawa H; Antes T; Goldberg GS
Oncogene; 2009 Dec; 28(48):4272-83. PubMed ID: 19767772
[TBL] [Abstract][Full Text] [Related]
3. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
[TBL] [Abstract][Full Text] [Related]
4. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation.
Cox BD; Natarajan M; Stettner MR; Gladson CL
J Cell Biochem; 2006 Sep; 99(1):35-52. PubMed ID: 16823799
[TBL] [Abstract][Full Text] [Related]
5. CAS promotes invasiveness of Src-transformed cells.
Brábek J; Constancio SS; Shin NY; Pozzi A; Weaver AM; Hanks SK
Oncogene; 2004 Sep; 23(44):7406-15. PubMed ID: 15273716
[TBL] [Abstract][Full Text] [Related]
6. Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate.
Li X; Jia Z; Shen Y; Ichikawa H; Jarvik J; Nagele RG; Goldberg GS
Cancer Sci; 2008 Jul; 99(7):1326-33. PubMed ID: 18422756
[TBL] [Abstract][Full Text] [Related]
7. Connexin 32 expression reduces malignant phenotype in human A549 adenocarcinoma cells: Implication of Src involvement.
Hada S; Sato H; Virgona N; Hagiwara H; Saito T; Suzuki K; Asano R; Yano T
Oncol Rep; 2006 Nov; 16(5):1149-54. PubMed ID: 17016607
[TBL] [Abstract][Full Text] [Related]
8. Focal adhesion targeting of v-Crk is essential for FAK phosphorylation and cell migration in mouse embryo fibroblasts deficient src family kinases or p130CAS.
Yeo MG; Sung BH; Oh HJ; Park ZY; Marcantonio EE; Song WK
J Cell Physiol; 2008 Mar; 214(3):604-13. PubMed ID: 17786957
[TBL] [Abstract][Full Text] [Related]
9. Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells.
Leroy C; Fialin C; Sirvent A; Simon V; Urbach S; Poncet J; Robert B; Jouin P; Roche S
Cancer Res; 2009 Mar; 69(6):2279-86. PubMed ID: 19276381
[TBL] [Abstract][Full Text] [Related]
10. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
[TBL] [Abstract][Full Text] [Related]
11. Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells.
Di Florio A; Capurso G; Milione M; Panzuto F; Geremia R; Delle Fave G; Sette C
Endocr Relat Cancer; 2007 Mar; 14(1):111-24. PubMed ID: 17395980
[TBL] [Abstract][Full Text] [Related]
12. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
[TBL] [Abstract][Full Text] [Related]
13. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo.
Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA
Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of loss of Fhl1 expression in human gastric cancer.
Sakashita K; Mimori K; Tanaka F; Kamohara Y; Inoue H; Sawada T; Hirakawa K; Mori M
Ann Surg Oncol; 2008 Aug; 15(8):2293-300. PubMed ID: 18465173
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic c-Abl provides a molecular 'Rheostat' controlling carcinoma cell survival and invasion.
Kain KH; Gooch S; Klemke RL
Oncogene; 2003 Sep; 22(38):6071-80. PubMed ID: 12955086
[TBL] [Abstract][Full Text] [Related]
16. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.
Hui AY; Meens JA; Schick C; Organ SL; Qiao H; Tremblay EA; Schaeffer E; Uniyal S; Chan BM; Elliott BE
J Cell Biochem; 2009 Aug; 107(6):1168-81. PubMed ID: 19533669
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis.
Martínez-Iglesias O; Garcia-Silva S; Tenbaum SP; Regadera J; Larcher F; Paramio JM; Vennström B; Aranda A
Cancer Res; 2009 Jan; 69(2):501-9. PubMed ID: 19147563
[TBL] [Abstract][Full Text] [Related]
18. Integrin-regulated FAK-Src signaling in normal and cancer cells.
Mitra SK; Schlaepfer DD
Curr Opin Cell Biol; 2006 Oct; 18(5):516-23. PubMed ID: 16919435
[TBL] [Abstract][Full Text] [Related]
19. Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells.
Goldberg GS; Alexander DB; Pellicena P; Zhang ZY; Tsuda H; Miller WT
J Biol Chem; 2003 Nov; 278(47):46533-40. PubMed ID: 12972425
[TBL] [Abstract][Full Text] [Related]
20. PLCgamma1 is essential for early events in integrin signalling required for cell motility.
Jones NP; Peak J; Brader S; Eccles SA; Katan M
J Cell Sci; 2005 Jun; 118(Pt 12):2695-706. PubMed ID: 15944397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
